Humana Inc. (NYSE:HUM) Stock Has Consensus Target Price of $453.30 According to Brokerages

Humana Inc. (NYSE:HUM) has received an average recommendation of “Moderate Buy” from the thirty-two analysts that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twenty-one have assigned a buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $453.30.

HUM has been the subject of a number of research analyst reports. Wolfe Research reaffirmed an “outperform” rating and issued a $450.00 target price on shares of Humana in a research note on Monday, August 24th. Royal Bank Of Canada lifted their price target on Humana from $246.00 to $415.00 and gave the company a “sector perform” rating in a research note on Thursday, July 9th. Raymond James Financial upgraded Humana from a “market perform” rating to an “outperform” rating and set a $520.00 price target on the stock in a report on Monday, October 12th. Lake Street Capital began coverage on Humana in a research report on Thursday, July 30th. They set a “buy” rating for the company. Finally, Bank of America upgraded Humana from a “neutral” rating to a “buy” rating and set a $500.00 price objective for the company in a report on Wednesday, July 29th.

Hedge Funds Weigh In On Humana

Several hedge funds have recently made changes to their positions in the business. BlackRock Inc. bought a new stake in Humana in the 2nd quarter valued at about $4,138,160,000. Pzena Investment Management LLC grew its position in shares of Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after purchasing an additional 1,398,774 shares in the last quarter. Assenagon Asset Management S.A. grew its position in shares of Humana by 20,126.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider’s stock worth $479,053,000 after purchasing an additional 1,249,272 shares in the last quarter. Legal & General Group Plc bought a new position in shares of Humana during the second quarter worth approximately $329,760,000. Finally, Barrow Hanley Mewhinney & Strauss LLC bought a new position in shares of Humana during the second quarter worth approximately $314,922,000. 92.38% of the stock is owned by institutional investors.

Humana Price Performance

NYSE HUM opened at $421.56 on Friday. The business has a 50 day simple moving average of $397.95 and a 200 day simple moving average of $351.07. Humana has a 52-week low of $163.11 and a 52-week high of $456.50. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a market cap of $50.62 billion, a price-to-earnings ratio of 39.88, a PEG ratio of 2.59 and a beta of 0.74.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business’s quarterly revenue was up 26.2% on a year-over-year basis. During the same period last year, the company posted $6.27 EPS. Analysts anticipate that Humana will post 9.03 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be given a dividend of $0.8850 per share. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 dividend on an annualized basis and a yield of 0.8%. Humana’s dividend payout ratio is 33.49%.

About Humana

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.